Relmada Therapeutics (RLMD) Competitor Comparison
We are evaluating the key criteria listed to compare Relmada Therapeutics (RLMD) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
35 / 54Gross Profits
0 / 39Total Revenue
0 / 50EBITDA
0 / 53Free Cashflow
46 / 54Quick Ratio
4 / 54Earnings per Share
48 / 54Dividend yield
0 / 5Total Cash
24 / 54Performance 3 years
42 / 54Performance 5 years
42 / 54Performance 10 years
47 / 54Linearity 3 years
36 / 54Linearity 5 years
32 / 54Linearity 10 years
45 / 54Total Rank
52 / 54Dividend Rank
32 / 54Valuation Rank
45 / 54Piotroski Rank
45 / 54Muliplier Rank
51 / 54Market Capitalization - RLMD ranking 35 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.